Simon Galbraith
Angel Investor · at Cade Hill Investments
Cambridge, United Kingdom
Simon Galbraith is a seed investor at Cade Hill Investments in Cambridge focused on Software and Health Care. Simon is the joint founder and CEO of Redgate Software. Over the past 15 years, Simon has been part of Redgate’s growth from a 2 person firm operating out of a spare room to today’s 300 person outfit with hundreds of thousands of users. Although Simon’s responsibilities are primarily strategic, his background is technical with qualificationsincluding a PhD in physics from Cambridge University and former employment with Shell and ThornEMI.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Simon Galbraith invests in
Stages Simon Galbraith invests in
Countries Simon Galbraith invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 1 (33%)
- Health Care 1 (33%)
- Life Science 1 (33%)
- Biotechnology 1 (33%)
- Enterprise Software 1 (33%)
Stage
- Seed 1 (33%)
- Pre-Seed 1 (33%)
- Venture - Series Unknown 1 (33%)
Country
- Croatia 1 (33%)
- United Kingdom 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| SysKit is a software development company focused on creating a state-of-the-art platform for easy management and governance of Microsoft 365 environments. Steering cumbersome and complex environments has never been easier. Our flagship product SysKit Point simplifies IT management, enhances security and provides IT control through one centralizeddashboard. Our goal is simple. To support IT professionals, business users, and organizations in achieving flexible collaboration and peace of mind. World-renowned organizations from different industries and sizes recognize our capability and dedication to creating user-friendly, unique, and simple solutions. Our 3800+ customers value our continuous effort in upgrading products that make a real difference. | $9M / Venture - Series Unknown / Dec 13, 2022 | ||
| BoobyBiome uses specialist expertise and research to develop a probiotic supplement for infants with compromised microbiomes. They aim to promote healthy infant development by recreating the beneficial bacteria associated with breast milk. | $1.7M / Pre-Seed / Sep 08, 2022 | ||
| BoobyBiome uses specialist expertise and research to develop a probiotic supplement for infants with compromised microbiomes. They aim to promote healthy infant development by recreating the beneficial bacteria associated with breast milk. | $1.7M / Seed / Mar 29, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Simon Galbraith invest in?
Simon Galbraith invests primarily in Software, Health Care and Life Science startups, most often at Seed and Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in Croatia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Simon Galbraith?
Public channels for Simon Galbraith include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Simon Galbraith last invest?
The most recent investment recorded for Simon Galbraith closed in Dec 2022. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!